Equity Bancshares, Inc. (EQBK)

Enfusion Stock Forecast

Stock Price Forecast

The 5 analysts that cover Enfusion stock have a consensus rating of "Buy" and an average price target of $45.6, which forecasts a 24.73% increase in the stock price over the next year. The lowest target is $44 and the highest is $49.

Price Target: $45.60 (+24.73%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$44	$45.6	$45	$49
Change	+20.35%	+24.73%	+23.09%	+34.03%

Analyst Ratings

The average analyst rating for Enfusion stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Feb '25	Mar '25	Apr '25	May '25	Jun '25	Jul '25
Strong Buy	0	0	0	0	0	0
Buy	3	3	3	3	3	3
Hold	2	2	3	3	3	3
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	5	5	6	6	6	6

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Jeff Rulis DA Davidson	DA Davidson	Hold Maintains $39 → $44	Hold	Maintains	$39 → $44	+20.35%	Jul 16, 2025
Chris Mcgratty Keefe, Bruyette & Woods	Keefe, Bruyette & Woods	Hold Maintains $44 → $45	Hold	Maintains	$44 → $45	+23.09%	Jul 16, 2025
Andrew Liesch Piper Sandler	Piper Sandler	Buy Maintains $46 → $44	Buy	Maintains	$46 → $44	+20.35%	Apr 17, 2025
Jeff Rulis DA Davidson	DA Davidson	Hold Maintains $40 → $39	Hold	Maintains	$40 → $39	+6.67%	Apr 17, 2025
Chris Mcgratty Keefe, Bruyette & Woods	Keefe, Bruyette & Woods	Hold Maintains $46 → $44	Hold	Maintains	$46 → $44	+20.35%	Apr 7, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

266.52M

Increased by 20.94%

from 220.37M

Revenue Next Year

293.38M

Increased by 10.08%

from 266.52M

EPS This Year

3.85

Decreased by -3.80%

from 4.00

EPS Next Year

4.50

Increased by 16.83%

from 3.85

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	132.27M	183.33M	197.74M	138.12M	220.37M	266.52M	293.38M
Revenue Growth	-0.18%	38.61%	7.86%	-30.15%	59.55%	20.94%	10.08%
EPS	-4.97	3.43	3.51	0.50	4.00	3.85	4.50
EPS Growth	-	-	2.33%	-85.76%	700.00%	-3.80%	16.83%
Forward PE	-	-	-	-	-	9.50	8.13
No. Analysts	-	-	-	-	-	7	7

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026
High	281.6M	304.5M
Avg	266.5M	293.4M
Low	253.4M	279.8M

Revenue Growth

Revenue Growth	2025	2026
High	27.8%	14.3%
Avg	20.9%	10.1%
Low	15.0%	5.0%

EPS Forecast

EPS	2025	2026
High	4.06	4.67
Avg	3.85	4.50
Low	3.61	4.25

EPS Growth

EPS Growth	2025	2026
High	1.6%	21.4%
Avg	-3.8%	16.8%
Low	-9.8%	10.5%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.